Ikuyama S, Shimura H, Hoeffler J P, Kohn L D
Laboratory of Biochemistry and Metabolism, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Mol Endocrinol. 1992 Oct;6(10):1701-15. doi: 10.1210/mend.6.10.1333054.
The "minimal" promoter region of the TSH receptor gene, -195 to -39 basepairs (bp), exhibits basal promoter activity, thyroid specificity, and negative regulation by TSH via its cAMP signal. In FRT thyroid cells and by comparison to pTRCAT5'-199, 5'-deletion mutants of chloramphenicol acetyltransferase (CAT) constructs from -199 to -150 bp of the minimal promoter decrease basal CAT activity by 50%, whereas continued deletion to -146 bp increases activity more than 4-fold. Continued deletion to -131 bp results in basal activity less than that of the -199 bp construct. An octameric cAMP response element (CRE)-like sequence, TGAGGTCA, is within -146 to -131 bp and starts at -139 bp. Its mutation to a consensus CRE (TGACGTCA) or AP1 (TGAGTCA) site or mutation of several residues flanking its 3'-terminus can improve promoter activity as much as 8-fold compared to pTRCAT5'-199. A nonpalindromic mutation to CGAGGACA decreases basal promoter activity to the level of the 199-bp minimal promoter. The CRE-like sequence between -139 and -132 bp is a constitutive enhancer of promoter activity in FRT thyroid cells, since, ligated to a simian virus-40-promoter-driven CAT gene, it increases CAT activity in the absence of forskolin in proportion to copy number and independent of direction or position. It can, however, function as a cAMP-responsive CRE, as evidenced by the fact that forskolin increases the activity of the same simian virus-40-promoter-driven CAT gene constructs in Buffalo rat liver (BRL) cells. DNAase-I footprinting shows that the CRE region is protected by a purified binding region peptide of the CRE-binding protein, activating transcription factor-2, and recombinant AP1 (human c-jun) as well as by BRL, FRT, and FRTL-5 rat thyroid cell nuclear extracts. Gel mobility shift analyses show that multiple CRE-binding proteins in the BRL, FRT, and FRTL-5 cell nuclear extracts form complexes with the CRE-like site, that one of these is CRE-binding protein, and that all form complexes with mutant sequences of the CRE-like site in a manner that exactly parallels their effects on constitutive enhancer function in FRT thyroid cells. We show, therefore, that the CRE-like site in the minimal TSH receptor promoter functions as a constitutive enhancer of promoter activity in FRT thyroid cells yet is a cAMP-responsive CRE.(ABSTRACT TRUNCATED AT 400 WORDS)
促甲状腺激素(TSH)受体基因的“最小”启动子区域,即-195至-39碱基对(bp),表现出基础启动子活性、甲状腺特异性以及TSH通过其环磷酸腺苷(cAMP)信号进行的负调控。在FRT甲状腺细胞中,与pTRCAT5'-199相比,最小启动子-199至-150 bp的氯霉素乙酰转移酶(CAT)构建体的5'缺失突变体使基础CAT活性降低50%,而继续缺失至-146 bp则使活性增加超过4倍。继续缺失至-131 bp导致基础活性低于-199 bp构建体。一个八聚体cAMP反应元件(CRE)样序列TGAGGTCA位于-146至-131 bp之间,起始于-139 bp。将其突变为共有CRE(TGACGTCA)或AP1(TGAGTCA)位点,或其3'末端侧翼几个残基的突变,与pTRCAT5'-199相比,可使启动子活性提高多达8倍。突变为CGAGGACA的非回文突变将基础启动子活性降低至199 bp最小启动子的水平。-139至-132 bp之间的CRE样序列是FRT甲状腺细胞中启动子活性的组成型增强子,因为与猿猴病毒40启动子驱动的CAT基因连接后,在不存在福斯可林的情况下,它可按拷贝数增加CAT活性,且与方向或位置无关。然而,它可作为cAMP反应性CRE发挥作用,这一事实证明,福斯可林可增加布法罗大鼠肝(BRL)细胞中相同猿猴病毒40启动子驱动的CAT基因构建体的活性。DNA酶I足迹分析表明,CRE区域受到CRE结合蛋白、激活转录因子-2的纯化结合区域肽、重组AP1(人c-jun)以及BRL、FRT和FRTL-5大鼠甲状腺细胞核提取物的保护。凝胶迁移率变动分析表明,BRL、FRT和FRTL-5细胞核提取物中的多种CRE结合蛋白与CRE样位点形成复合物,其中之一是CRE结合蛋白,并且所有这些蛋白都以与它们对FRT甲状腺细胞中组成型增强子功能的影响完全平行的方式与CRE样位点的突变序列形成复合物。因此,我们表明,最小TSH受体启动子中的CRE样位点在FRT甲状腺细胞中作为启动子活性的组成型增强子发挥作用,但同时也是cAMP反应性CRE。(摘要截短于400字)